arrow
S

Sigurður Y. Kristinsson

University of Iceland
H指数:62
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Detailed immunophenotypic and genetic characterization of bone marrow clonal plasma cells and B-cells in early-stage monoclonal gammopathies

早期单克隆丙种球蛋白病患者骨髓克隆性浆细胞和B细胞的详细免疫表型及遗传学特征分析

2026-07-180
OA
Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study

SARS-CoV-2疫苗接种对意义未明的单克隆丙种球蛋白血症的影响:基于人群的iStopMM研究的结果

2026-04-110
OAAI
Dietary intake and the risk of monoclonal gammopathy of undetermined significance: results from the population-based iStopMM screening study

饮食摄入与意义未明的单克隆丙种球蛋白病的风险:来自基于人群的iStopMM筛查研究的结果

2026-04-080
OAAI
Antimicrobial Use and Serious Infections Among Patients With Psoriatic Arthritis After Initiating Tumor Necrosis Factor Inhibitors: A Nationwide Matched Cohort Study (vol 52, pg 1098, 2025)

银屑病关节炎患者在使用肿瘤坏死因子抑制剂后抗菌药物使用与严重感染情况:一项全国性匹配队列研究(卷52,页1098,2025)

2026-02-010
PRE
Evaluating the real-world value of daratumumab addition to multiple myeloma induction therapy by real-world minimal residual disease assessment and extended genetic profiling

通过真实世界微小残留病灶评估和扩展性遗传谱分析,评估将daratumumab加入多发性骨髓瘤诱导治疗中的实际应用价值。

2025-11-100
OAAI
Antimicrobial Use and Serious Infections Among Patients With Psoriatic Arthritis After Initiating Tumor Necrosis Factor Inhibitors: A Nationwide Matched Cohort Study

银屑病关节炎患者应用肿瘤坏死因子抑制剂治疗后抗菌药物与严重感染的关系: 一项全国性匹配队列研究

2025-11-010
PRE
Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study

弥漫性多发性骨髓瘤患者感染风险增加:来自筛查的iStopMM研究的结果

Leukemia
IF13.4
2025-09-120
OAAI
Next-generation flow cytometry analysis of clonal bone marrow plasma cells identifies an indolent subset of MGUS

下一代流式细胞术分析克隆性骨髓浆细胞,识别出一类惰性MGUS亚群

2025-08-210
OAAI
Correction: Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis

修正:修订后的游离轻链参考区间可增强意义未明的单克隆 gammopathy 的风险分层,并减少过度诊断

2025-05-270
OAAI
The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance: a flow cytometry sub-study of the iStopMM screening study

游离轻链比值在意义未明的轻链型单克隆免疫球蛋白血症中的意义:iStopMM筛查研究中的流式细胞术亚组研究

2024-12-180
OAAI
Analysis of smoldering multiple myeloma according to the target of the monoclonal immunoglobulin of patients
2024-12-110
OAAI
Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population-based screening study
2024-11-190
OAAI
Deciphering the genetics and mechanisms of predisposition to multiple myeloma

解读多发性骨髓瘤易感性的遗传学和机制

2024-08-052
OAAI
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance
2024-06-180
PRE
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma

关于多发性骨髓瘤先兆临床试验优化设计的圆桌讨论

2024-05-012
OA
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined SignificanceA Cohort Study Nested in a Clinical Trial
2024-04-011
PRE
Prior cancer and risk of monoclonal gammopathy of undetermined significance: a population-based study in Iceland and Sweden
2024-01-110
OAAI
Trends of perceived disruption in healthcare services during the pandemic: findings from the COVID-19 National Resilience Cohort in Iceland
2023-12-210
OAAI